← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA8658.0x12.7x19.5x
EV / LTM revenue12700.7x1.6x3.5x
Premium to unaffected price115920%32%52%
Premium to 30-day VWAP22116%34%48%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
0901792009: 11 deals, 2 clean on every measure2009112010: 179 deals, 40 clean on every measure20101792011: 164 deals, 92 clean on every measure20111642012: 133 deals, 117 clean on every measure20121332013: 155 deals, 136 clean on every measure20131552014: 98 deals, 85 clean on every measure2014982015: 121 deals, 108 clean on every measure20151212016: 156 deals, 142 clean on every measure20161562017: 120 deals, 109 clean on every measure20171202018: 127 deals, 113 clean on every measure20181272019: 115 deals, 108 clean on every measure20191152020: 87 deals, 73 clean on every measure2020872021: 119 deals, 99 clean on every measure20211192022: 112 deals, 98 clean on every measure20221122023: 108 deals, 86 clean on every measure20231082024: 133 deals, 109 clean on every measure20241332025: 121 deals, 98 clean on every measure20251212026: 62 deals, 52 clean on every measure202662
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector
Healthcare: 18.4x median across 84 dealsHealthcare18.4xn=84Technology: 16.7x median across 170 dealsTechnology16.7xn=170Real Estate: 16.2x median across 51 dealsReal Estate16.2xn=51Business Services: 12.8x median across 74 dealsBusiness Services12.8xn=74Industrials: 12.7x median across 116 dealsIndustrials12.7xn=116Financials: 12.7x median across 25 dealsFinancials12.7xn=25Utilities: 12.1x median across 58 dealsUtilities12.1xn=58Consumer & Retail: 10.3x median across 141 dealsConsumer & Retail10.3xn=141Materials: 9.6x median across 40 dealsMaterials9.6xn=40Other: 9.5x median across 31 dealsOther9.5xn=31Media & Telecom: 9.3x median across 41 dealsMedia & Telecom9.3xn=41Energy: 8.5x median across 34 dealsEnergy8.5xn=34
Deals by sector
Technology: 421 dealsTechnology421Healthcare: 315 dealsHealthcare315Consumer & Retail: 245 dealsConsumer & Retail245Industrials: 234 dealsIndustrials234Financials: 216 dealsFinancials216Business Services: 155 dealsBusiness Services155Real Estate: 142 dealsReal Estate142Media & Telecom: 85 dealsMedia & Telecom85Energy: 82 dealsEnergy82Utilities: 79 dealsUtilities79Materials: 78 dealsMaterials78Other: 69 dealsOther69
Deals by buyer type
Financial sponsor: 123 dealsFinancial sponsor123Strategic: 1073 dealsStrategic1073Management / founder: 2 dealsManagement / founder2Controlling holder: 10 dealsControlling holder10Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 913 dealsUnclassified913
Deals by enterprise value
Under $250m: 809 dealsUnder $250m809$250m to $1bn: 489 deals$250m to $1bn489$1bn to $5bn: 538 deals$1bn to $5bn538$5bn to $20bn: 211 deals$5bn to $20bn211Over $20bn: 31 dealsOver $20bn31Not computed: 43 dealsNot computed43
Deals by industry code
Business Services & Software: 390 dealsBusiness Services & Sof…390Chemicals, Pharmaceuticals & Allied Products: 204 dealsChemicals, Pharmaceutic…204Electronics & Electrical Equipment: 149 dealsElectronics & Electrica…149Instruments, Medical Devices & Optical Goods: 109 dealsInstruments, Medical De…109Holding & Other Investment Offices: 96 dealsHolding & Other Investm…96Electric, Gas & Sanitary Services: 79 dealsElectric, Gas & Sanitar…79Insurance Carriers: 72 dealsInsurance Carriers72Industrial Machinery & Computers: 69 dealsIndustrial Machinery & …69Health Services: 69 dealsHealth Services69Communications: 65 dealsCommunications65
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
Turquoise Hill Resources Ltd.
2022-09-29 (filed) · Take-private · $43.00 a share
Held out of the multiples: no balance sheet at announcement: EV = equity value
Board book on file →
46117 Yukon Inc.
Strategic
Materials$8.7bnn.a.n.a.
67%
SC 13E3
All cash
Granite Ridge Resources, Inc.
2022-09-29 (filed) · Public merger · $11.50 a share
Not named in the filing
Unclassified
Energy-$44mn.a.-0.1x
n.a.
DEFM14A
All cash
Store Capital LLC
2022-09-15 · Public merger · $32.25 a share
Ivory REIT, LLC
Strategic
Real Estate$9.1bnn.a.10.6x
20%
DEFM14A
All cash
Seritage Growth Properties
2022-09-14 (filed) · Public merger · $19.29 a share
Held out of the multiples: EV / LTM revenue 345.0x above 60x
Not named in the filing
Unclassified
Real Estate$931mn.a.345.0x
n.a.
DEFM14A
All cash
Channeladvisor Corp
2022-09-04 · Public merger · $23.10 a share
CommerceHub, Inc.
Strategic
Technology$579m26.5x3.4x
57%
DEFM14A
All cash
Signify Health, Inc.
2022-09-02 · Public merger · $30.50 a share
CVS Pharmacy, Inc.
Strategic
Healthcare$5.3bnn.a.6.3x
n.a.
DEFM14A
All cash
Hill International, Inc.
2022-08-26 · Public merger · $3.40 a share
Not named in the filing
Unclassified
Business Services$232m16.2xn.a.
92%
DEFM14A
All cash
Aerie Pharmaceuticals Inc
2022-08-22 · Public merger · $15.25 a share
Alcon Research, LLC
Strategic
Healthcare$568mn.a.2.7x
39%
DEFM14A
All cash
Avalara, Inc.
2022-08-08 · Public merger · $93.50 a share
Lava Intermediate, Inc.
Strategic
Technology$6.8bnn.a.8.6x
27%
DEFM14A
All cash
Global Blood Therapeutics, Inc.
2022-08-07 · Public merger · $68.50 a share
Pfizer Inc.
Strategic
Healthcare$4.4bnn.a.18.5x
102%
110% to VWAP
DEFM14A
All cash
Cyberoptics Corp
2022-08-07 · Public merger · $54.00 a share
Nordson Corporation
Strategic
Industrials$380m18.7x3.7x
n.a.
DEFM14A
All cash
Irobot Corp
2022-08-04 · Public merger · $51.75 a share
Amazon.com, Inc.
Strategic
Technology$1.3bnn.a.n.a.
n.a.
25% to VWAP
DEFM14A
All cash
Irobot Corp
2022-08-04 · Public merger · $61.00 a share
Amazon.com, Inc.
Strategic
Technology$1.6bnn.a.n.a.
22%
48% to VWAP
DEFM14A
All cash
Atlas Air Worldwide Holdings Inc
2022-08-04 · Public merger · $102.50 a share
Rand Parent, LLC
Unclassified
Other$4.4bn4.1x1.0x
11%
DEFM14A
All cash
ChemoCentryx, Inc.
2022-08-03 · Public merger · $52.00 a share
Held out of the multiples: EV / LTM revenue 91.3x above 60x
Not named in the filing
Unclassified
Healthcare$3.4bnn.a.91.3x
116%
DEFM14A
All cash
Ping Identity Holding Corp.
2022-08-02 · Public merger · $28.50 a share
Project Polaris Holdings, LP
Strategic
Technology$2.5bnn.a.8.2x
63%
DEFM14A
All cash
EVO Payments, Inc.
2022-08-01 · Public merger · $34.00 a share
Held out of the multiples: EV / LTM EBITDA 0.9x outside 1x to 75x
Global Payments Inc.
Strategic
Business Services$149m0.9x0.3x
n.a.
DEFM14A
All cash
Constellation Brands, Inc.
2022-08-01 (filed) · Take-private · $64.64 a share
Board book on file →
A&z 2015 Business Holdings LP
Financial sponsor
Consumer & Retailn.a.n.a.n.a.
n.a.
SC 13E3
All cash
Cowen Inc.
2022-08-01 · Public merger · $39.00 a share
The Toronto-Dominion Bank
Strategic
Financials$146mn.a.0.1x
49%
DEFM14A
All cash
Stealth BioTherapeutics Corp
2022-07-31 · Take-private · $0.38 a share
Board book on file →
Equal Talent Investments LTD
Financial sponsor
Healthcare$234mn.a.n.a.
34%
SC 13E3
All cash
Realnetworks Inc
2022-07-27 · Take-private · $0.73 a share
Board book on file →
GH Sliver, Inc.
Strategic
Technology$20mn.a.0.4x
55%
SC 13E3
All cash
Pzena Investment Management, Inc.
2022-07-26 · Take-private · $9.60 a share
Board book on file →
Panda Merger Sub, LLC
Controlling holder
Financials$498m4.6x2.4x
n.a.
SC 13E3
All cash
Shell Midstream Partners, L.P.
2022-07-25 · Take-private · $15.85 a share
Board book on file →
Shell USA, Inc.
Strategic
Energy$5.9bn22.1x11.9x
n.a.
25% to VWAP
SC 13E3
All cash
Hanger, Inc.
2022-07-21 · Public merger · $18.75 a share
Hero Parent, Inc.
Unclassified
Healthcare$1.2bn11.7x1.0x
26%
29% to VWAP
DEFM14A
All cash
1Life Healthcare Inc
2022-07-20 · Public merger · $18.00 a share
Amazon.com, Inc.
Strategic
Healthcare$3.1bnn.a.3.5x
83%
DEFM14A
All cash

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More